Healthcare Costs and Carbon Emissions of Stage III Melanoma Surveillance Imaging
More frequent surveillance imaging of patients with stage III melanoma is associated with higher healthcare costs and environmental impacts, the latter of which are responsible for a small proportion of total costs when valued in dollars.
Authors
- Mbathio Dieng (ORCID: https://orcid.org/0000-0001-6714-9633)
- Rachael L. Morton (ORCID: https://orcid.org/0000-0001-7834-0572)
- Jake T. W. Williams (ORCID: https://orcid.org/0000-0001-8394-2682)
- Katy Bell (ORCID: https://orcid.org/0000-0002-0137-3218)
- Scott McAlister (ORCID: https://orcid.org/0000-0001-8702-6374)
Institutions
- The University of Sydney (AU)
- The University of Melbourne (AU)
Publication Details
- Journal
- Applied Health Economics and Health Policy
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1007/s40258-025-00998-1
- Primary Topic
- Climate Change and Health Impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hunter New England Local Health District
- University of Sydney
- Melanoma Institute Australia
- Medical Research Council
- National Health and Medical Research Council
- Faculty of Medicine and Health, University of Sydney